December 13, 2002
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
New FDA head promises quicker drug approval times
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WASHINGTON — The Food and Drug Administration will crack down harder on deceptive pharmaceutical marketing and increase the speed of its drug approval process, according to Mark McClellan, MD, the agency’s new director.
In an interview with The New York Times, Dr. McClellan said he wanted to accelerate the approval process for brand-name and generic drugs as well as for medical devices. He said another goal for his agency will be more aggressive policing of claims made to the public in prescription drug advertising.